TY - JOUR AU - Holman, R. R. AU - Paul, S. K. AU - Bethel, M. A. AU - Matthews, D. R. AU - Neil, H. A. PY - 2008 DA - 2008// TI - 10-year follow-up of intensive glucose control in type 2 diabetes JO - N Engl J Med VL - 359 UR - https://doi.org/10.1056/NEJMoa0806470 DO - 10.1056/NEJMoa0806470 ID - Holman2008 ER - TY - JOUR PY - 1998 DA - 1998// TI - Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) JO - Lancet VL - 352 UR - https://doi.org/10.1016/S0140-6736(98)07037-8 DO - 10.1016/S0140-6736(98)07037-8 ID - ref2 ER - TY - JOUR AU - Giugliano, D. AU - Standl, E. AU - Vilsboll, T. AU - Betteridge, J. AU - Bonadonna, R. AU - Campbell, I. AU - Schernthaner, G. AU - Staels, B. AU - Trichopoulou, A. AU - Farinaro, E. PY - 2009 DA - 2009// TI - Is the current therapeutic armamentarium in diabetes enough to control the epidemic and its consequences? What are the current shortcomings? JO - Acta Diabetol VL - 46 UR - https://doi.org/10.1007/s00592-009-0134-3 DO - 10.1007/s00592-009-0134-3 ID - Giugliano2009 ER - TY - JOUR AU - Kanai, Y. AU - Lee, W. S. AU - You, G. AU - Brown, D. AU - Hediger, M. A. PY - 1994 DA - 1994// TI - The human kidney low affinity Na+/glucose cotransporter SGLT2. Delineation of the major renal reabsorptive mechanism for D-glucose JO - J Clin Invest VL - 93 UR - https://doi.org/10.1172/JCI116972 DO - 10.1172/JCI116972 ID - Kanai1994 ER - TY - JOUR AU - Wells, R. G. AU - Pajor, A. M. AU - Kanai, Y. AU - Turk, E. AU - Wright, E. M. AU - Hediger, M. A. PY - 1992 DA - 1992// TI - Cloning of a human kidney cDNA with similarity to the sodium-glucose cotransporter JO - Am J Physiol VL - 263 ID - Wells1992 ER - TY - JOUR AU - You, G. AU - Lee, W. S. AU - Barros, E. J. AU - Kanai, Y. AU - Huo, T. AU - Khawaja, S. AU - Wells, R. AU - Nigam, S. AU - Hediger, M. PY - 1995 DA - 1995// TI - Molecular characteristics of Na(+)-coupled glucose transporters in adult and embryonic rat kidney JO - J Biol Chem VL - 270 UR - https://doi.org/10.1074/jbc.270.49.29365 DO - 10.1074/jbc.270.49.29365 ID - You1995 ER - TY - JOUR AU - Bakris, G. L. AU - Fonseca, V. A. AU - Sharma, K. AU - Wright, E. M. PY - 2009 DA - 2009// TI - Renal sodium-glucose transport: role in diabetes mellitus and potential clinical implications JO - Kidney Int VL - 75 UR - https://doi.org/10.1038/ki.2009.87 DO - 10.1038/ki.2009.87 ID - Bakris2009 ER - TY - JOUR AU - Nishimura, M. AU - Naito, S. PY - 2005 DA - 2005// TI - Tissue-specific mRNA expression profiles of human ATP-binding cassette and solute carrier transporter superfamilies JO - Drug Metab Pharmacokinet VL - 20 UR - https://doi.org/10.2133/dmpk.20.452 DO - 10.2133/dmpk.20.452 ID - Nishimura2005 ER - TY - JOUR AU - Idris, I. AU - Donnelly, R. PY - 2009 DA - 2009// TI - Sodium-glucose co-transporter-2 inhibitors: an emerging new class of oral antidiabetic drug JO - Diabetes Obes Metab VL - 11 UR - https://doi.org/10.1111/j.1463-1326.2008.00982.x DO - 10.1111/j.1463-1326.2008.00982.x ID - Idris2009 ER - TY - JOUR AU - Wright, E. M. AU - Turk, E. PY - 2004 DA - 2004// TI - The sodium/glucose cotransport family SLC5 JO - Pflugers Arch VL - 447 UR - https://doi.org/10.1007/s00424-003-1202-0 DO - 10.1007/s00424-003-1202-0 ID - Wright2004 ER - TY - JOUR AU - Santer, R. AU - Kinner, M. AU - Lassen, C. L. AU - Schneppenheim, R. AU - Eggert, P. AU - Bald, M. AU - Brodehl, J. AU - Daschner, M. AU - Ehrich, J. AU - Kemper, M. AU - Li Volti, S. AU - Neuhaus, T. AU - Skovby, F. AU - Swift, P. AU - Schaub, J. AU - Klaerke, D. PY - 2003 DA - 2003// TI - Molecular analysis of the SGLT2 gene in patients with renal glucosuria JO - J Am Soc Nephrol VL - 14 UR - https://doi.org/10.1097/01.ASN.0000092790.89332.D2 DO - 10.1097/01.ASN.0000092790.89332.D2 ID - Santer2003 ER - TY - JOUR AU - Handlon, A. L. PY - 2005 DA - 2005// TI - Sodium glucose co-transporter 2 (SGLT2) inhibitors as potential antidiabetic agents JO - Expert Opin Ther Pat VL - 13 UR - https://doi.org/10.1517/13543776.15.11.1531 DO - 10.1517/13543776.15.11.1531 ID - Handlon2005 ER - TY - JOUR AU - Hussey, E. AU - Clark, R. AU - Amin, D. AU - Kipnes, M. AU - O’Connor-Semmes, R. AU - O’Driscoll, E. AU - Leong, L. AU - Murray, S. AU - Dobbins, R. AU - Layko, D. AU - Nunez, D. PY - 2010 DA - 2010// TI - The single-dose pharmacokinetics and pharmacodynamics of sergliflozin etabonate, a novel inhibitor of glucose reabsorption, in healthy volunteers and subjects with type 2 diabetes mellitus JO - J Clin Pharmacol VL - 50 UR - https://doi.org/10.1177/0091270009351879 DO - 10.1177/0091270009351879 ID - Hussey2010 ER - TY - JOUR AU - Isaji, M. PY - 2007 DA - 2007// TI - Sodium-glucose cotransporter inhibitors for diabetes JO - Curr Opin Investig Drugs VL - 8 ID - Isaji2007 ER - TY - JOUR AU - Komoroski, B. AU - Vachharajani, N. AU - Feng, Y. AU - Li, L. AU - Kornhauser, D. AU - Pfister, M. PY - 2009 DA - 2009// TI - Dapagliflozin, a novel, selective SGLT2 inhibitor, improved glycemic control over 2 weeks in patients with type 2 diabetes mellitus JO - Clin Pharmacol Ther VL - 85 UR - https://doi.org/10.1038/clpt.2008.250 DO - 10.1038/clpt.2008.250 ID - Komoroski2009 ER - TY - JOUR AU - Komoroski, B. AU - Vachharajani, N. AU - Boulton, D. AU - Kornhauser, D. AU - Geraldes, M. AU - Li, L. AU - Pfister, M. PY - 2009 DA - 2009// TI - Dapagliflozin, a novel SGLT2 inhibitor, induces dose-dependent glucosuria in healthy subjects JO - Clin Pharmacol Ther VL - 85 UR - https://doi.org/10.1038/clpt.2008.251 DO - 10.1038/clpt.2008.251 ID - Komoroski2009 ER - TY - JOUR AU - Asano, T. AU - Ogihara, T. AU - Katagiri, H. AU - Sakoda, H. AU - Ono, H. AU - Fujishiro, M. AU - Anai, M. AU - Kurihara, H. AU - Uchijima, Y. PY - 2004 DA - 2004// TI - Glucose transporter and Na+/glucose cotransporter as molecular targets of anti-diabetic drugs JO - Curr Med Chem VL - 11 UR - https://doi.org/10.2174/0929867043364360 DO - 10.2174/0929867043364360 ID - Asano2004 ER - TY - JOUR AU - Ehrenkranz, J. R. AU - Lewis, N. G. AU - Kahn, C. R. AU - Roth, J. PY - 2005 DA - 2005// TI - Phlorizin: a review JO - Diabetes Metab Res Rev VL - 21 UR - https://doi.org/10.1002/dmrr.532 DO - 10.1002/dmrr.532 ID - Ehrenkranz2005 ER - TY - JOUR AU - Katsuno, K. AU - Fujimori, Y. AU - Takemura, Y. PY - 2007 DA - 2007// TI - Sergliflozin, a novel selective inhibitor of low-affinity sodium glucose cotransporter (SGLT2), validates the critical role of SGLT2 in renal glucose reabsorption and modulates plasma glucose level JO - J Pharmacol Exp Ther VL - 320 UR - https://doi.org/10.1124/jpet.106.110296 DO - 10.1124/jpet.106.110296 ID - Katsuno2007 ER - TY - JOUR AU - Fujimori, Y. AU - Katsuno, K. AU - Nakashima, I. AU - Ishikawa-Takemura, Y. AU - Fujikura, H. AU - Isaji, M. PY - 2008 DA - 2008// TI - Remogliflozin etabonate, in a novel category of selective low-affinity sodium glucose cotransporter (SGLT2) inhibitors, exhibits antidiabetic efficacy in rodent models JO - J Pharmacol Exp Ther VL - 327 UR - https://doi.org/10.1124/jpet.108.140210 DO - 10.1124/jpet.108.140210 ID - Fujimori2008 ER - TY - JOUR AU - Harrington, W. W. AU - Milliken, N. O. AU - Binz, J. G. PY - 2008 DA - 2008// TI - Remogliflozin etabonate, a potent and selective sodium-dependent glucose transporter 2 antagonist, produced sustained metabolic effects in zucker diabetic fatty rats JO - Diabetes VL - 58 ID - Harrington2008 ER - TY - JOUR AU - Wright, E. M. AU - Turk, E. AU - Martin, M. G. PY - 2002 DA - 2002// TI - Molecular basis for glucose-galactose malabsorption JO - Cell Biochem Biophys VL - 36 UR - https://doi.org/10.1385/CBB:36:2-3:115 DO - 10.1385/CBB:36:2-3:115 ID - Wright2002 ER - TY - JOUR AU - Sigafoos, J. AU - Bowers, G. AU - Castellino, S. AU - Culp, A. G. AU - Wagner, D. S. AU - Reese, J. M. AU - Humphreys, J. E. AU - Hussey, E. K. AU - O’Connor-Semmes, R. L. AU - Kapur, A. AU - Tao, W. AU - Dobbins, R. L. AU - Polli, J. W. PY - 2012 DA - 2012// TI - Assessment of the drug interaction risk for remogliflozin etabonate, a sodium-dependent glucose cotransporter-2 inhibitor: evidence from in vitro, human mass balance, and ketoconazole interaction studies JO - Drug Metab Dispos VL - 40 UR - https://doi.org/10.1124/dmd.112.047258 DO - 10.1124/dmd.112.047258 ID - Sigafoos2012 ER - TY - JOUR AU - Yabe, D. AU - Watanabe, K. AU - Sugawara, K. AU - Kuwata, H. AU - Kitamoto, Y. AU - Sugizaki, K. AU - Fujiwara, S. AU - Hishizawa, M. AU - Hyo, T. AU - Kuwabara, K. AU - Yokota, K. AU - Iwasaki, M. AU - Kitatani, N. AU - Kurose, T. AU - Inagaki, N. AU - Seino, Y. PY - 2012 DA - 2012// TI - Comparison of incretin immunoassays with or without plasma extraction: Incretin secretion in Japanese patients with type 2 diabetes JO - J Diabetes Investig VL - 3 UR - https://doi.org/10.1111/j.2040-1124.2011.00141.x DO - 10.1111/j.2040-1124.2011.00141.x ID - Yabe2012 ER - TY - JOUR AU - Deacon, C. F. AU - Holst, J. J. AU - Sugawara, K. PY - 2009 DA - 2009// TI - Immunoassays for the incretin hormones GIP and GLP-1 JO - Best Pract Res Clin Endocrinol Metab VL - 23 UR - https://doi.org/10.1016/j.beem.2009.03.006 DO - 10.1016/j.beem.2009.03.006 ID - Deacon2009 ER - TY - JOUR AU - O’Connor-Semmes, R. AU - Hussey, E. K. AU - Dobbins, R. L. AU - Nunez, D. J. PY - 2008 DA - 2008// TI - Simulation and prediction of long-term clinical efficacy in type 2 diabetes resulting from inhibition of the renal sodium-glucose cotransporter 2 (SGLT2) JO - Diabetes VL - 57 ID - O’Connor-Semmes2008 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/2050-6511/14/26/prepub UR - http://www.biomedcentral.com/2050-6511/14/26/prepub ID - ref27 ER -